CFLAR and prostate cancer: Although published studies have demonstrated that 2-ME2 inhibits prostate cancer cell growth by suppressing transcriptional activation of c-FLIP, the molecular mechanism through which 2-ME2 suppresses c-FLIP activation is not defined [13].